All Type of News
Pharmaceutical disputes focused on ‘composition/substance patents’
It has been a year since the enforcement of the Patent Linkage System(15 March 2015).
Although fierce conflicts were made among original companies owning patents and second movers during the period, ‘composition pate...
First domestic establishment of ‘Chronic Heart Failure Therapy Guideline’
The chronic heart failure therapy guideline was first established and unveiled in Korea.
On the 15th, the Korean Society of Heat Failure, a subsidiary of the Korean Society of Cardiology, established and announced th...
SK Biopharmaceuticals’ new epilepsy drug increases expectation for US FDA approvalA SK Biopharmaceuticals’ new epilepsy drug has been increasingly expected to acquire immediate approval from the U.S. FDA.
According to the industry concerned on the 15th, ‘YK...
|
Will sales of ‘Enbrel’ increase by the launch of its biosimilar?
The launch of biosimilar ‘Brenzys’ decreased the health insurance benefit of ‘Enbrel’ by 30%, enlarging the price competition against Enbrel. Their prescriptions will be increased jointly through the effect of the lau...
Galderma’s gel-type facial flushing treatment about to be launched in Korea
A gel-type facial blushing treatment is expected to be commercialized in the domestic market.
According to the industry concerned on the 29th, Galderma has acquired domestic approval of ‘Mirvaso,’ a self-developed ge...
What are domestic potential drugs to be exported globally?
Both pharmaceutical companies and biopharmaceutical ventures are actively researching and developing new drugs having potentials to be expanded into the global market. In particular, technological exports are expected...
KRW 1.86 trillion cashable assets by listed pharmaceutical companies
Cashable assets owned by listed pharmaceutical companies have continuously increased.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the 2015 audit reports turned in by KOSPI and KOSDAQ listed ph...
Rare disease drugs, ‘Abraxane-Lemtrada,’ land in Seoul National University Hospital
2 types of new drugs for severe diseases that were insufficient in treatments were landed in Seoul National University Hospital.
The Seoul National University Hospital pharmacy department unveiled the list of drugs t...
KPA proposes its opinions to Saenuri Party
The Korean Pharmaceutical Association(KPA) delivered the pharmaceutical industry’s current policy issues to the Saenuri Party and gave orders to invigorate the public health pharmacists system and the generic substitu...
For the year of the Patent Linkage System adoption, there was no major impact
It has been a year since the adoption of the Patent Linkage System. Fortunately for the pharmaceutical industry, the concerns that were expected before the adoption seems not reflected yet.
The Patent Linkage System...
